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Cholesterol and sphingomyelin (SM) associate in raft domains and are metabolically coregulated. One aspect of coordi-
nate regulation occurs in the Golgi apparatus where oxysterol binding protein (OSBP) mediates sterol-dependent
activation of ceramide transport protein (CERT) activity and SM synthesis. Because CERT transfer activity is dependent
on its phosphatidylinositol 4 phosphate [PtdIns(4)P]-speciﬁc pleckstrin homology domain, we investigated whether
OSBP activation of CERT involved a Golgi-associated PtdIns 4-kinase (PI4K). Cell fractionation experiments revealed that
Golgi/endosome-enriched membranes from 25-hydroxycholesterol-treated Chinese hamster ovary cells had increased
activity of a sterol-sensitive PI4K that was blocked by small interfering RNA silencing of OSBP. Consistent with this
sterol-requirement, OSBP silencing also reduced the cholesterol content of endosome/trans-Golgi network (TGN) frac-
tions containing PI4KII. PI4KII, but not PI4KIII, was required for oxysterol-activation of SM synthesis and recruit-
ment of CERT to the Golgi apparatus. However, neither PI4KII nor PI4KIII expression was required for 25-hydroxy-
cholesterol–dependent translocation of OSBP to the Golgi apparatus. The presence of OSBP, CERT, and PI4KII in the
TGN of oxysterol-stimulated cells suggests that OSBP couples sterol binding or transfer activity with regulation of
PI4KII activity, leading to CERT recruitment to the TGN and increased SM synthesis.
INTRODUCTION
As a consequence of physical association in detergent-resis-
tant membranes or raft domains, the metabolism of choles-
terol and sphingomyelin (SM) is tightly coupled (Ridgway,
2000). The capacity of plasma membrane rafts to absorb
cholesterol is dictated by SM content, which ultimately af-
fects feedback regulation of de novo cholesterol synthesis
and esteriﬁcation in the endoplasmic reticulum (ER) (Porn
and Slotte, 1990; Scheek et al., 1997; Leppimaki et al., 1998).
Similarly, experimental and pathophysiological conditions
that alter cellular cholesterol levels cause reciprocal changes
in SM mass and synthesis (Ridgway, 2000). The Golgi appa-
ratus is the site of assembly of cholesterol, SM, glycosphin-
golipids, and proteins into preraft membranes (Brown and
Rose, 1992; Heino et al., 2000). De novo sphingolipid synthe-
sis required for membrane assembly in late Golgi compart-
ments is dependent on transfer proteins for delivery of
ceramide and glucosylceramide (GlcCer) precursors from
the ER (Hanada et al., 2003; D’Angelo et al., 2007; Halter et al.,
2007). Cholesterol synthesized in the ER or released during
lipoprotein degradation in the endosomal/lysosomal com-
partment is also delivered to the Golgi apparatus and
plasma membrane by ill-deﬁned nonvesicular mechanisms
(reviewed in Ikonen, 2008). Collectively this points to an
essential, integrative role for cholesterol and sphingolipid
transfer proteins during the initial stages of raft domain
assembly at the Golgi apparatus.
Ceramide transfer protein (CERT; Hanada et al., 2003) and
the GlcCer transfer protein FAPP2 (D’Angelo et al., 2007; Halter
et al., 2007) functionally link metabolic pathways by delivering
ER-derived precursors to the Golgi apparatus for sphingolipid
synthesis. In contrast, the ﬁnal product of the mevalonate path-
way, cholesterol, must be exported from the ER against a
concentration gradient (Lange, 1991). Cholesterol transport
from the ER is energy and temperature dependent but does not
involve a vesicular mechanism (Urbani and Simoni, 1990;
Heino et al., 2000), indirectly supporting a role for transport
proteins in cholesterol delivery from the ER to the plasma
membrane or trans Golgi/trans-Golgi network (TGN). Numer-
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4141ous proteins with sterol-binding folds have been identiﬁed that
could fulﬁll this transport function; however, only two are
reported to speciﬁcally interact with the ER and Golgi appara-
tus; oxysterol binding protein (OSBP) and OSBP-related pro-
tein 9 (ORP9) (Ridgway et al., 1992; Wyles and Ridgway, 2004).
Both belong to the 12-member OSBP gene family that is char-
acterized by a C-terminal cholesterol/oxysterol binding do-
main (Olkkonen and Levine, 2004). OSBP and ORP9L also
contain two phenylalanines in an acid tract (FFAT) motifs that
binds vesicle-associated membrane protein-associated protein
(VAP) in the ER (Wyles et al., 2002; Wyles and Ridgway, 2004),
and phosphatidylinositol 4 phosphate [PtdIns(4)P]-speciﬁc
pleckstrin homology (PH) domains that interact with the Golgi
apparatus (Lagace et al., 1997; Levine and Munro, 2002; Wyles
and Ridgway, 2004). The yeast OSBP homologue Osh4p
(Raychaudhuri et al., 2006), OSBP, and ORP9L (Ngo and Ridg-
way, 2009) catalyze in vitro phosphatidylinositol (PtdIns)-
phosphate–dependent sterol transfer activity, indicating that
the in vivo function of this family could be transfer of choles-
terol, oxysterols, or both between membranes. The cholesterol
transfer activity of ORP9L has been implicated in ER–Golgi
protein trafﬁcking and maintenance of endosomal cholesterol
content (Ngo and Ridgway, 2009). In contrast, OSBP mediates
sterol-dependent recruitment of CERT to the Golgi apparatus,
resulting in increased ceramide transfer and SM synthesis
(Perry and Ridgway, 2006), and negatively regulates ABCA1
expression and cholesterol efﬂux in a post-Golgi compartment
by an SM-independent mechanism (Bowden and Ridgway,
2008). Because both of these functions required the sterol bind-
ing activity of OSBP, which also displays cholesterol transfer
activity in vitro (Ngo and Ridgway, 2009), a possible mecha-
nism could involve modulation of the sterol content of target
membranes.
Recruitment of CERT to the Golgi apparatus by OSBP seems
to involve a secondary mediator and not a direct physical
interaction (Perry and Ridgway, 2006). Because CERT interac-
tion with the Golgi apparatus is dependent on its PtdIns(4)P-
speciﬁc PH domain (Hanada et al., 2003), we tested whether
25-hydroxycholesterol and OSBP activated a PtdIns 4-kinase
(PI4K) that mediated CERT recruitment to the Golgi apparatus.
In vitro analysis of PI4K activity in a Golgi/endosome-en-
riched fraction from control and oxysterol-treated Chinese
hamster ovary (CHO) cells, coupled with small interfering
RNA (siRNA) experiments, revealed that PI4KIIwas required
for oxysterol activation of SM synthesis and CERT recruitment
to the Golgi. The reported dependence of PI4KII activity on
cholesterol suggests that OSBP could regulate kinase activity
by altering its membrane environment.
MATERIALS AND METHODS
Materials
pEGFP-CERT and pEGFP-PI4KII were described previously (Perry and
Ridgway, 2006; Waugh et al., 2006). Alexa Fluor488-conjugated and unconju-
gated giantin antibodies were purchased from Covance (Emeryville, CA).
Antibodies against adaptin and PI4KIII were from BD Biosciences Trans-
duction Laboratories (Mississauga, ON, Canada). An antibody against early
endosomal antigen 1 (EEA1) was from Afﬁnity Bioreagents (Golden, CO).
Sheep anti-human TGN46 and rabbit anti-mouse TGN38 antibodies were
from AbD Serotec (Raleigh, NC) and Novus Biologicals (Littleton, CO), re-
spectively. Antibodies against OSBP were described previously (Ridgway et
al., 1998). Anti-CERT immunoglobulin (Ig)Y, horseradish peroxidase-conju-
gated rabbit anti-IgY, and Opti-Prep density gradient media were purchased
from Sigma-Aldrich (Oakville, ON, Canada). Mouse monoclonal antibody
(mAb) 1C4 was generated according to standard methods using recombinant
rat PI4KII expressed in Sf9 cells as immunogen. 1C4 speciﬁcally recognizes
the PI4KII isoform from human, rat, and hamster species. The 1C4 hybrid-
oma line was cultured in RPMI 1640 medium containing 2.5% ultralow IgG
fetal calf serum (FCS) (Invitrogen, Paisley, United Kingdom) and supple-
mented with 5% Doma-Drive (Immune Systems, Bristol, United Kingdom).
Culture supernatants were used in indirect immunoﬂuorescence (1:2 dilution)
and Western immunoblotting (1:4 dilution). We purchased [3H]serine and
[32P]-ATP from PerkinElmer-Cetus (Woodbridge, ON, Canada). PtdIns(4)P,
PtdIns, SM, and ceramide were from Sigma-Aldrich or Echelon (Salt Lake
City, UT).
Cell Culture and Transfections
CHO cells were cultured in DMEM containing 5% FCS and proline (34
g/ml) (medium A). In some experiments, cells were cultured in DMEM
containing 5% lipoprotein deﬁcient serum (LPDS). In CHO cells, siRNAs
against OSBP (siOSBP2) (Perry and Ridgway, 2006), PI4KII (5-GAGAC-
GAGCCCGCUAGUGUUU-3), and PI4KIII (5-GCAAG GAGCCUGUGUU-
CAUUU-3) (Dharmacon RNA Technologies, Lafayette, CO) were used at a
concentration of 30, 60, and 30 nM, respectively, to silence expression of the
respective genes by using TransIT TKO transfection reagent (Mirus, Madison,
WI). An exact sequence match between siRNAs and the hamster PI4KII and
PI4KIII mRNAs was conﬁrmed by polymerase chain reaction (PCR) ampli-
ﬁcation and sequencing of the respective cDNAs. HeLa cells cultured in
DMEM with 5% FCS were transfected with siRNAs against human PI4KIII
(siRNA1, 5-AGAAAGGGAGUGAGGACUAUU-3; siRNA2, 5-GUUUAAC-
CGCAUCGGGCUAUU-3) and PI4KIII (siRNA1, 5-GGGAUGACCUUCG-
GCAAGAUU-3; siRNA2, 5-GCUGAUUGCCGCUCGGAAAUU-3) (Dhar-
macon RNA Technologies) by using TransIT TKO transfection reagent.
Controls consisted of an identical concentration of two different nontargeting
siRNA (siNT) with at least four mismatches with known human and mouse
genes that were used interchangeably with similar results.
CHO cells stably expressing green ﬂuorescent protein (GFP)-CERT were
prepared by transfection with pEGFP-CERT by using Lipofectamine 2000 and
selection in medium A containing G418 (600 g/ml) for 14 d. Cells stably
expressing the fusion protein were maintained in medium A with 300 g
G418/ml. OSBP was silenced in CHO cells by stable expression of shOSBP
(Perry and Ridgway, 2006) by using a lentiviral vector (Block-iT Lentiviral
shRNA Expression; Invitrogen) and selection in blasticidin (10 g/ml) for 2
wk. Control cells stably expressing shOSBP containing three silent mutations
to prevent activity (Perry and Ridgway, 2006) were prepared in an identical
manner.
Subcellular Fractionation of CHO Cells
Golgi-enriched membranes were isolated on discontinuous sucrose gradients
(Balch et al., 1984). In brief, CHO cells were scraped from 100-mm dishes;
resuspended in 10 mM Tris-HCl, pH 7.4, 0.25 M sucrose 2 mM EDTA, 2 mM
EGTA, 1 mM sodium pyrophosphate, 1 mM NaF, and 200 nM okadaic acid
and protease inhibitors (Roche Diagnostics, Mannheim, Germany); and dis-
rupted by 20 strokes in a Dounce homogenizer. The cell homogenate (0.9 ml)
was mixed with 0.9 ml of 2.3 M sucrose in a 5-ml centrifuge tube, overlaid
with 2.1 ml of 1.2 M sucrose followed by 1.2 ml of 0.8 M sucrose. The
gradients were subject to centrifugation for4ha t110,000  g by using an
SW55 Ti rotor (Beckman Coulter, Fullerton, CA). Fractions were collected
corresponding to the 0.8 M sucrose layer (fraction I), the 0.8 M/1.2 M interface
(fraction II), the 1.2 M sucrose layer (fraction II), the 1.2 M/1.3 M interface
(fraction IV), and the 1.3 M layer (fraction V). Fraction II is enriched 25- to
40-fold in the activity of SM synthase, a Golgi enzyme, but also contains
endosomes (Lagace et al., 1999).
-Octylglucoside (-OG)/deoxycholate (DOC) insoluble membranes were
fractionated and assayed for PI4K activity as described previously (Waugh et
al., 2003). In brief, CHO cells were solubilized in 2 ml of 10 mM -OG/4 mM
DOC, 100 mM Na2CO3, 10 mM EDTA, and 10 mM EGTA, pH 11.0, by
sonication (6 5-s bursts) on ice. The resulting homogenate was mixed with an
equal volume of 90% (wt/vol) sucrose/20 mM Tris-HCl, pH 7.4, in a 12-ml
centrifuge tube and overlaid with 4 ml of 35% sucrose (wt/vol) and 5%
sucrose (wt/vol). The gradient was subject to centrifugation at 175,000  g for
16 h by using an SW41 Ti rotor (Beckman Coulter), and fractions (1.3 ml) were
collected and assayed for PI4K activity as described below.
CHO cells stably expressing shOSBP or a nontargeting control were ho-
mogenized in 0.25 M sucrose, 1 mM EDTA, and 10 mM Tris-HCl, pH 7.4, by
15 passages through a 25-gauge needle and centrifuged for 10 min at 2000 
g. The postnuclear supernatant was then fractionated on 6–26% Opti-Prep
density gradients (1.059–1.156 g/ml) by centrifugation at 200,000  g for 3 h
in an SW55 Ti rotor (Urano et al., 2008). Fractions were collected by aspiration
and assayed for unesteriﬁed cholesterol content by the Amplex Red method
according to the manufacturer’s instructions (Invitrogen). The distribution of
cellular organelles in the gradient was determined by immunoblotting for
VAP A (ER), NPC1 (late endosomes), TGN38 (TGN), and caveolin (endo-
somes/plasma membrane).
Measurement of PI4K Activity
PI4K activity was assayed as described, with minor changes (Waugh et al.,
1998). In brief, PI4K activity in CHO membrane fractions (2–5 g of protein)
was assayed in 25 mM HEPES, pH 7.4, 20 mM MgCl2, and 2 g of phospha-
tidylinositol (from a 2 mg/ml stock in 0.2% Triton X-100) in a ﬁnal volume of
100 l. The reaction was initiated by the addition of 40 M[ 32P]-ATP (0.25
Ci/nmol), incubated at 37°C for 5 min, and terminated by the addition of 0.5
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in a solvent system of CHCl3:acetone:MeOH:acetic acid:H2O (40:15:18:12:10,
vol/vol), and 32P-labeled lipids were visualized by autoradiography. Bands
corresponding to [32P]PtdIns(4)P (determined with an authentic standard)
were scraped and quantiﬁed by scintillation counting.
Immunoﬂuorescence Microscopy
CHO cells were ﬁxed in 4% (wt/vol) paraformaldehyde for 15 min at 20°C
and permeabilized in 0.05% (vol/vol) Triton X-100 for 10 min at 4°C (Perry
and Ridgway, 2006). Cells were treated with phosphate-buffered saline (PBS)
containing 1% (wt/vol) bovine serum albumin, and incubated with primary
and Alexa Fluor-conjugated secondary antibodies as indicated in ﬁgure leg-
ends. Cells were washed twice with PBS and mounted on microscope slides
with Mowiol 4-88 (Calbiochem, San Diego, CA). To disperse the Golgi appa-
ratus, cells were treated with nocodazole (2 g/ml) for 30 min before the
ﬁxation step. Fluorescence images were captured using an LSM510/AxioVert
100M inverted microscope (Carl Zeiss, Thornwood, NY) equipped with 63
and 100 oil immersion objectives (numerical aperture [NA] 1.4).
Cholesterol was visualized by incubating cells with ﬁlipin (50 g/ml in PBS)
for 30 min followed by mounting in Mowiol 4-88. Images were captured at
identical exposure times using an Axiovert 200M ﬂuorescence microscope (Carl
Zeiss) equipped with an axioCam HRm charge-coupled device camera, 4,6-
diamidino-2-phenylindole ﬁlter package, and 63 oil immersion objective (NA
1.4).
GFP-CERT has a complex pattern of cellular localization but translocates to
multiple perinuclear Golgi structures in the presence of 25-hydroxycholes-
terol. To quantify the change in GFP-CERT localization, images of control and
oxysterol-treated CHO cells were captured under identical conditions, and
ImageJ software (National Institutes of Health, Bethesda, MD) was used to set
pixel thresholds for images of solvent-treated control cells. The change in
pixel area above threshold values (normalized to cell number) was measured
in oxysterol-activated cells to determine the relative increase in GFP-CERT
translocation to perinuclear Golgi structures.
Metabolic Labeling of Sphingolipids
CHO or HeLa cells were transiently transfected with PI4KIII or PIKII
siRNAs for 48 or 72 h and treated with 25-hydroxycholesterol (2 g/ml) for
6 h, and then sphingolipids were labeled with [3H]serine (10 Ci/ml) for the
ﬁ n a l2ho ft h eoxysterol treatment. Radiolabeled SM, GlcCer, and ceramide
were extracted with CHCl3:MeOH, separated by TLC, and quantiﬁed by
scintillation counting (Perry and Ridgway, 2006).
RESULTS
A Golgi/Endosome-associated PI4K Activity Is Activated
by 25-Hydroxycholesterol and OSBP
Localization of OSBP, CERT, and FAPP2 to the Golgi appa-
ratus (Lagace et al., 1997; Levine and Munro, 2002; Hanada et
al., 2003; Wyles and Ridgway, 2004) involves interaction of
their PH domains with PtdIns(4)P synthesized by the Golgi-
resident kinases PI4KII and/or PI4KIII (Balla et al., 2005;
Toth et al., 2006; D’Angelo et al., 2007). Because OSBP pro-
motes sterol-dependent CERT translocation and increased
SM synthesis in the Golgi apparatus, we reasoned that this
could involve OSBP-dependent activation of a PI4K in the
Golgi apparatus. To test this, homogenates of control and
25-hydroxycholesterol-treated CHO cells were fractionated
on discontinuous sucrose gradients and analyzed for PI4K
expression and activity (Figure 1). This protocol separates
Golgi-enriched buoyant membranes (fraction II) from
denser ER, mitochondrial, and nuclear membranes (frac-
tions III–V) (Balch et al., 1984). Equivalent amounts (based
on volume) of each fraction were resolved by SDS-polyacryl-
amide gel electrophoresis (PAGE) and immunoblotted for
PI4KII, PI4KIII, OSBP, adaptin, EEA1, giantin, and
CERT (Figure 1A). Giantin, a Golgi resident protein, was
primarily detected in fraction II. The adaptin, a component
of the activator protein-1 complex involved in clathrin as-
sembly at the TGN (Bonifacino and Traub, 2003), also was
enriched in fraction II but was detected in other fraction as
well. Although fraction II was enriched in Golgi markers, it
also contained endosomes as indicate by enrichment in
EEA1 (Stenmark et al., 1996). PI4KII in control CHO ho-
mogenates was distributed throughout the gradient but was
enriched in fraction II. PI4KIII was detected in fraction II,
but the majority was in fractions IV and V. In contrast to
OSBP, CERT was enriched in fraction II and relatively absent
from dense fractions. Oxysterol treatment did not reproduc-
ibly affect the distribution of PI4KII, PI4KIII, or CERT in
any of the sucrose gradient fractions. Some fractions had
minor and inconsistent changes in OSBP and EEA1 distri-
bution in response to 25-hydroxycholesterol treatments.
Neither OSBP nor PI4KIII was enriched in fraction II of
control or oxysterol-treated cells, even though both dis-
played prominent Golgi staining (see Figure 9), indicating
dissociation from membranes during isolation. Fraction II
was not particularly enriched in PI4KII or PI4KIII (Figure
1A) but contained 30% of total PI4K activity, indicating it
represents a highly active fraction (Figure 1B; Waugh et al.,
2003). PI4K activity in fraction II was not affected by treat-
ment with 10 M wortmannin (data not shown), conﬁrming
the relative absence of PI4K type III isoforms (Nakanishi et
al., 1995).
We next tested whether PI4K activity in subcellular frac-
tions from CHO cells was responsive to 25-hydroxycholes-
terol. Total PI4K activity in homogenates (H) of oxysterol-
treated CHO cells was reduced by 20%, and the activity in
fractions I, III, IV, and V was similar to that of controls
(Figure 1C). However, PI4K activity in the Golgi/endosome-
enriched fraction II from oxysterol-treated cells has in-
creased by 40% compared with untreated controls. Increased
Figure 1. Analysis of an oxysterol-activated PI4K in the Golgi and
endosomes. (A) Homogenates of CHO cells, cultured in the absence
() or presence () of 25-hydroxycholesterol (25OH; 2.5 g/ml) for
1 h, were fractionated on discontinuous sucrose gradients. Equiva-
lent volumes of fractions I–V were resolved by SDS-PAGE and
immunoblotted for the indicated proteins as described in Materials
and Methods. (B) Sucrose gradient fractions of untreated CHO cell
homogenates were assayed for PI4K activity and expressed as a
percentage of total. Results are the mean and SEM of three experi-
ments. (C) Homogenates (H) of CHO cells treated with 25-hydroxy-
cholesterol (2.5 g/ml) or control solvent for 1 h were separated on
discontinuous sucrose gradients, and individual fractions were as-
sayed for PI4K activity and expressed relative to controls. Results
are the mean and SEM of three experiments. (D) Fraction II was
isolated from cells treated with 25-hydroxycholesterol for the indi-
cated times and assayed for PI4K activity. Results are expressed
relative to time-matched untreated controls (mean and SEM of 6
experiments).
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treated cells was not the result of increased PI4KII or
PI4KIII protein expression (Figure 1A). The time course for
25-hydroxycholesterol activation of PI4K activity in fraction
II is shown in Figure 1D. Treatment of CHO cells for 60 min
caused a maximal 75% increase in PI4K activity in fraction II
that declined at 90 min.
To conﬁrm that membrane-associated PI4K activity was
activated by 25-hydroxycholesterol, CHO cells were ex-
tracted with a -OG/DOC containing buffer, pH 11.0, and
fractionated on discontinuous sucrose gradients (Figure 2).
This method separates soluble kinases from a buoyant
-OG/DOC–resistant membrane fraction enriched in
PI4KII (Waugh et al., 2003). Similar to results with A431
cells (Waugh et al., 2003), PI4K activity in detergent extracts
of CHO cells was enriched in fraction 4, which correspond to
the 5–35% sucrose boundary (Figure 2A). Next, CHO cells
were treated with or without 25-hydroxycholesterol (2.5 g/
ml) for 1 h, solubilized in -OG/DOC buffer, separated on
sucrose gradients, and assayed for PI4K activity (Figure 2B).
Compared with untreated controls, oxysterols increased the
PI4K activity in fraction 4 by 35% and caused variable acti-
vation in fractions 5–7 that had less kinase activity. Immu-
noblotting of sucrose gradient fractions from control and
oxysterol-treated cells conﬁrmed that fraction IV was en-
riched in PI4KII and that oxysterol treatment did not affect
expression of the kinase (Figure 2C). -OG/DOC-resistant
membranes were enriched in the ER protein VAP but were
devoid of PI4KIII. Thus, two independent fractionation
methods show that a membrane-associated PI4K, possibly
the II isoform, was activated in response to 25-hydroxy-
cholesterol.
To test whether 25-hydroxycholesterol activation of PI4K
activity required OSBP, CHO cells were transfected with
siNT or siOSBP for 48 h, treated with or without 25-hydroxy-
cholesterol, homogenized, fractionated on sucrose gradients,
and assayed for PI4K activity (Figure 3). Compared with
nontargeting controls, siOSBP transfection reduced expres-
sion by 90% but did not affect PI4KII or PI4KIII (Figure
3A). A comparison of 25-hydroxycholesterol-dependent ac-
tivation of PI4K activity in individual fractions revealed that
fraction II from siNT-transfected cells displayed the ex-
pected 40% increase in PI4K activity in response to 25-
hydroxycholesterol (Figure 3B). However, PI4K activity in
this fraction from OSBP-depleted cells was resistant to acti-
vation by 25-hydroxycholesterol. Fraction I also displayed a
slight increase in PI4K activity that was suppressed by
knockdown of OSBP.
Palmitoylation of a CCPCC motif in the catalytic region of
PI4KII mediates cholesterol-dependent activity in the TGN
(Barylko et al., 2001; Waugh et al., 2003, 2006; Minogue et al.,
2010), suggesting it is a candidate for regulation by OSBP
and sterols. We tested whether the PI4K activity in fraction
II was due to the II isoform by examining sensitivity to
manipulation of cholesterol levels using methyl -cyclodex-
trin (MCD) or MCD complexed with cholesterol as de-
scribed previously (Waugh et al., 2006). To determine
whether altering cholesterol affected Golgi PI4K activity,
CHO cells were treated with MCD for 30 min followed by
incubation in lipid-depleted medium with or without cho-
lesterol supplementation (Figure 4A). Fraction II was iso-
lated from these cells, assayed for PI4K activity and com-
pared with control cells that were not pretreated with
MCD but cultured under identical conditions. PI4K activity
in fraction II from cholesterol-depleted cells cultured in li-
poprotein-deﬁcient serum (LPDS) was slightly reduced.
However, culturing cells in media supplemented with
MCD-cholesterol increased PI4K activity by 50% compared
with cells that received only LPDS. Similar to previous re-
sults using a Golgi/endosomal fraction from A431 cells
(Waugh et al., 2006), extraction of cholesterol from fraction II
with MCD caused a dose-dependent inhibition of PI4K
activity (Figure 4B). Supplementation of fraction II mem-
branes with MCD–cholesterol complex increased PI4K ac-
tivity to a maximum of 1.5-fold at 100 nmol cholesterol/
assay (Figure 4C). Interestingly, addition of 60 M 25-
hydroxycholesterol directly to fraction II membranes also
stimulated PI4K activity by 40–50% (data not shown).
Cholesterol sensitivity of PI4KII suggested it could be
associated with a cholesterol-enriched cellular compart-
Figure 2. PI4K activity in detergent-resistant membranes is stim-
ulated by 25-hydroxycholesterol. (A) Untreated CHO cells were
solubilized in -OG/DOC buffer, pH 11.0, separated on discontin-
uous sucrose gradients, and individual fractions were assayed for
PI4K activity. (B) -OG/DOC extracts of CHO cells treated with
25-hydroxycholesteorl (25OH) or control solvent were separated on
sucrose gradients and assayed for PI4K activity. Results are ex-
pressed relative to solvent-treated controls and are the mean and
SEM of four experiments. (C) Equivalent volumes of fractions pre-
pared as described in B were immunoblotted for PI4KII, PI4KIII,
and VAP.
Figure 3. PI4K activation by 25-hydroxycholesterol is dependent
on OSBP. (A) CHO cells were transfected with siNT or siOSBP for
48 h and subsequently cultured in the absence or presence of 25-
hydroxycholesterol (2.5 g/ml) for 1 h. Expression of OSBP,
PI4KII, or PI4KIII in cell homogenates from siNT- and siOSBP-
transfected CHO cells was determined by immunoblotting. (B) Ho-
mogenates of control and OSBP-depleted cells, treated with or with-
out 25-hydroxycholesterol, were separated on sucrose gradients and
fractions were assayed for PI4K activity. Activation of PI4K activity
by oxysterol is expressed relative to solvent-treated controls (mean
and SEM of 4 experiments).
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TGN localization (Balla et al., 2002; Salazar et al., 2005; Mi-
nogue et al., 2006; Craige et al., 2008), GFP-PI4KII was
present in perinuclear vesicles in control and 25-hydroxy-
cholesterol–treated cells (Figure 5A). Filipin staining of cho-
lesterol in the endosomes/lysosomes was also similar in
control and 25-hydroxycholesterol–treated CHO cells but
did not overlap with GFP-PI4KII. We also observed that
ﬁlipin distribution was unaffected by OSBP depletion with
siRNA (data not shown), suggesting it is not a good probe
for assessing the relationship between cholesterol distribu-
tion and PI4KII. We also measured whether activation by
25-hydroxycholesterol and OSBP affected the cholesterol
content of fraction II. However, cholesterol mass in fraction
II isolated from control and OSBP-depleted cells treated
with or without 25-hydroxycholesterol was similar (data not
shown). Although the sucrose density gradient method is
useful for quantifying changes in PI4K activity, it does not
have the resolution to identify subtle changes in the choles-
terol content of Golgi and endosomal membranes. For this
purpose, cholesterol and PI4KII distribution in control and
OSBP-depleted CHO cells were determined by fractionation
of postnuclear supernatants on Opti-Prep gradients (Figure
5, B and C). CHO cells were stably depleted of OSBP by
expression of a lentiviral short hairpin RNA (shRNA) that
afforded 95% knockdown of OSBP protein compared with
nontargeting control (shNT) (Figure 5C). PI4KII in shOSBP
and ShNT cells was distributed primarily to fractions con-
taining the endosomal marker NPC1 and partially over-
lapped with TGN38 (Figure 5C). Control shNT CHO cells
have a cholesterol peak in fractions 4–6 that comigrated
with NPC1and PI4KII (Figure 5B). In OSBP-depleted cells,
there was a signiﬁcant shift in cholesterol distribution from
fractions 4–6 to fractions 1 and 2 that contained TGN38 and
Figure 4. In vitro regulation of Golgi/endo-
somal PI4K activity by cholesterol. (A) CHO
cells were treated with or without 5 mM
MCD in DMEM for 30 min, washed twice in
DMEM, and incubated in DMEM with 5%
LPDS with or without MCD-cholesterol
(100 M) complex (LPDSChol). After 2 h,
cells were harvested, and fraction II was iso-
lated and assayed for PI4K activity. PI4K ac-
tivity is expressed relative to cells that were
not treated with MCD. Results are the mean
and SEM of three experiments. (B and C)
Golgi-enriched fraction II from CHO cells
was treated with the indicated concentrations
of MCD (B) or MCD-cholesterol complex (C) for 30 min at 37°C before assaying for PI4K activity. Results are expressed relative to
buffer-treated controls and are the mean and SEM of three experiments.
Figure 5. OSBP depletion reduces the choles-
terol content of Golgi/endosomal membranes
containing PI4KII. (A) The localization of cho-
lesterol was determined by ﬁlipin staining of
CHO cells transiently expressing PI4KII-GFP
and treated with or without 25-hydroxycholes-
terol (2.5 g/ml) for 60 min. (B) Equivalent
amounts (2–2.5 mg protein) of the postnuclear
supernatants from CHO cells expressing
shOSBP or a nontargeting control (shNT)
were fractionated on an Opti-Prep gradient
and assayed for unesteriﬁed cholesterol con-
tent as described in Materials and Methods. The
cholesterol content of individual fraction is
expressed as a percentage of the total choles-
terol recovered from the gradient and is the
mean and SEM of three experiments (*p 
0.05). (C) Distribution of the organelle mark-
ers NPC1 (late endosomes), TGN38 (Golgi),
VAP (ER), and caveolin (plasma membrane/
endosomes), as well as OSBP and PI4KII,
were determined by immunoblotting of
equivalent volumes of each fraction.
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altered by OSBP silencing, the distribution of PI4KII was
unaffected. PI4KII localization to a TGN/endosomal com-
partment that is subject to cholesterol depletion when OSBP
expression is reduced further supports the conclusion that
this kinase is regulated by a sterol- and OSBP-dependent
mechanism.
PI4KII Is Required for Activation of SM Synthesis by
25-Hydroxycholesterol
OSBP coordinates cholesterol transport and/or signaling
with SM synthesis by activation of CERT activity between
the ER and Golgi apparatus (Perry and Ridgway, 2006).
PI4KII is a good candidate for mediating CERT recruitment
to the Golgi apparatus, but other PI4Ks could be involved.
Indeed, PI4KIII is abundant in the Golgi apparatus and has
a dominant, although apparently not exclusive role in
CERT-dependent ceramide transport to the Golgi apparatus
under unstimulated conditions (Toth et al., 2006; D’Angelo et
al., 2007). To test whether PI4KII or PI4KIII was involved
in oxysterol regulation of SM synthesis, their expression was
silenced in CHO cells with siRNAs followed by metabolic
labeling of sphingolipids with [3H]serine in the presence and
absence of 25-hydroxycholesterol (Figure 6A). Treatment of
siNT-transfected cells with 25-hydroxycholesterol resulted
in a 2.5-fold increase in [3H]serine incorporation into SM
without affecting [3H]ceramide and [3H]GlcCer levels. CHO
cells in which PI4KII expression was reduced by 80% had
basal [3H]SM synthesis that was similar to siNT controls;
however, activation of [3H]SM synthesis by oxysterol was
blocked. Silencing of PI4KII also reduced synthesis of
[3H]GlcCer in control and oxysterol-treated CHO cells, an
effect that was not observed after OSBP and CERT depletion
(Perry and Ridgway, 2006). In contrast, silencing of PI4KIII
did not affect basal or 25-hydroxycholesterol-activated SM
synthesis. To conﬁrm these results, oxysterol-activated SM
synthesis was quantiﬁed in HeLa cells using two different
siRNAs directed against PI4KII and PI4KIII (Figure 6B).
25-Hydroxycholesterol activation of SM synthesis in HeLa
cells is suppressed by OSBP silencing. Moreover, knock-
down of PI4KII with two different siRNAs suppressed
oxysterol-activated SM synthesis by 50%, but silencing of
PI4KIIII had no affect.
Increased SM synthesis in oxysterol-treated cells is accom-
panied by Golgi translocation of CERT and delivery of a
ﬂuorescent-labeled ceramide analogue from the ER (Perry
and Ridgway, 2006). Thus, we tested whether CERT recruit-
ment to the Golgi was also dependent on expression of
PI4KII. GFP-CERT was stably expressed in CHO cells, and
localization to the Golgi apparatus was visualized after de-
pletion of PI4KII or PI4KIII by RNA interference (RNAi)
and treatment with 25-hydroxycholesterol (Figure 7). siR-
NAs were effective in knocking down PI4KII and III
protein expression by 90% in CHO cells expressing GFP-
CERT (Figure 7A). GFP-CERT was in a diffuse and pe-
rinuclear compartment in solvent-treated siNT cells but
displayed strong Golgi localization in cells exposed to 25-
hydroxycholesterol (Figure 7B). Depletion of PI4KII did not
affect the distribution of CERT in untreated control cells;
however, the addition of 25-hydroxycholesterol failed to
promote translocation to the Golgi apparatus (Figure 7B). In
PI4KIII-depleted cells, the distribution of GFP-CERT was
similar to untreated siNT controls and addition of 25-hy-
droxycholesterol increased the translocation of GFP-CERT
to the Golgi apparatus. However, CERT-GFP was slightly
dispersed in PI4KIII knockdown cells compared with siNT
controls, indicating fragmentation of the Golgi stacks. The
quantiﬁcation of GFP-CERT localization conﬁrmed that
siNT- and siPI4KIII-transfected cells treated with 25-hy-
droxycholesterol had increased perinuclear Golgi staining
compared with PI4KII knockdown cells (Figure 7C). These
result show that, consistent with effects on SM synthesis,
PI4KII mediates 25-hydroxycholesterol–dependent recruit-
ment of CERT to the Golgi apparatus without affecting its
distribution under basal conditions.
PI4KII and PI4KIII Are Not Required for Golgi
Localization of OSBP
Results shown in Figures 6 and 7 indicated that OSBP is an
upstream regulator of PI4KII. However, PI4KIII and
PI4KII have been implicated in recruitment of the GFP-PH
Figure 6. siRNA silencing of PI4KII prevents 25-hydroxycholes-
terol activation of SM synthesis. (A) CHO cells were transfected
with siNT, siPI4KII, or siPI4KIII for 48 or 72 h. Cells were then
treated with solvent (gray bars) or 25-hydroxycholesterol (2.5 g/
ml; black bars) for 6 h. During the last2ho foxysterol treatment,
cells were pulse labeled with [3H]serine. and isotope incorporation
into SM, ceramide and GlcCer was quantiﬁed as described in Ma-
terials and Methods. Results are the mean and SEM of three to six
separate experiments. The extent of PI4KII and PI4KIII knock-
down was determined by immunoblotting of whole cell lysates by
using actin as a load control. *p  0.05 compared with oxysterol-
treated siNT. (B) HeLa cells were transfected with two different
siRNAs against PI4KII or PI4KIII, or siOSBP, for 48 h. 25-Hy-
droxycholesterol–stimulated SM synthesis was then measured as
described in A. Results are expressed relative to solvent treated
controls and are the mean and SEM of three separate experiments.
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Balla et al., 2005), implying that PtdIns(4)P production also
could initiate or enhance OSBP interaction with the Golgi
apparatus. Whereas previous studies used the isolated OSBP
PH domain as a PtdIns(4)P reporter, siRNA silencing was
used here to establish the role of PI4KII and PI4KIII in
Figure 8. Colocalization of OSBP, CERT, PI4KII, and PI4KIII at the TGN. (A) CHO cells were treated with 25-hydroxycholesterol (2.5 g/ml)
for 30 min followed by addition of nocodazole (2 g/ml) for an additional 30 min. Endogenous OSBP was detected with a polyclonal antibody
followed by goat anti-rabbit Alexa Fluor488- or Alexa Fluor594-conjugated secondary antibodies. Cells were costained for giantin or PI4KIII by
using corresponding Alexa Fluor488- or Alexa Fluor594-conjugated secondary antibodies. CHO cells transiently expressing GFP-CERT were
immunostained for OSBP as described above using a goat anti-rabbit Alexa Fluor594-conjugated secondary antibody. (B) HeLa cells were
immunostained with a sheep anti-goat TGN46 antibody and a goat anti-sheep Alexa488-conjugated secondary antibody. This was followed by
polyclonal or monoclonal antibodies against OSBP, PI4KII, or PI4KII and appropriate Alexa Fluor594-conjugated secondary antibodies. Images
are single confocal sections (0.2–0.4 m) obtained as described in Materials and Methods and the legend to Figure 7.
Figure 7. Knockdown of PI4KII prevents
oxysterol-mediated translocation of GFP-
CERT to the Golgi apparatus. (A) Knockdown
of PI4KII or PI4KIII in CHO cells stably
expressing GFP-CERT was conﬁrmed by im-
munoblotting as described in Materials and
Methods. (B) GFP-CERT was visualized by
confocal microscopy in CHO cells in which
PI4KII or PI4KIII was knocked down by
90%. Images are single optical sections (0.4–
0.2 mM) captured using an LSM510/AxioVert
100M inverted microscope equipped with a
100 oil immersion objective (NA 1.4). In
some experiments, the absence of PI4KII and
PI4KIII expression also was conﬁrmed by
coimmunoﬂuorescence as described in the
legend to Figure 9. (C) Localization of GFP-
CERT to perinuclear Golgi structures was
quantiﬁed in 63 wide-ﬁeld images of control
and oxysterol-treated CHO cells transfected
with siNT, siPI4KII, or siPI4KIII as de-
scribed in Materials and Methods. Results are
the mean and SEM of three experiments.
OSBP Regulates PI4KII
Vol. 21, December 1, 2010 414725-hydroxycholesterol–dependent recruitment of endogenous
OSBP to the Golgi apparatus. First, the localization of OSBP,
PI4KIII, PI4KII, and CERT was identiﬁed after activation
with 25-hydroxycholesterol and fragmentation of the Golgi
apparatus into mini-stacks with nocodazole (Godi et al., 2004;
Figure 8). In CHO cells (Figure 8A), OSBP did not colocalize
with giantin in the cis/medial-Golgi but strongly colocalized
with PI4KIII in the cis/medial- (Weixel et al., 2005) or trans-
Golgi/TGN (Hausser et al., 2005). OSBP also partially localized
with endogenous PI4KII in the endosomes/TGN (Figure 9;
Salazar et al., 2005; Minogue et al., 2006; Craige et al., 2008), and
strongly costaining with GFP-CERT, which is also reported in
the TGN (Fugmann et al., 2007). Because antibodies to TGN
resident proteins reacted poorly with CHO cells, we conﬁrmed
the localization of OSBP and the PI4-kinases with TGN46 in
HeLa cells (Figure 8B). Consistent with the implied TGN local-
ization in CHO cells, OSBP and PI4KIII strongly colocalized
with TGN46. Perinuclear PI4KII also costained with TGN46,
but there was still a portion that did not and, based on cell
fractionation shown in Figure 5C, probably corresponds to the
endosomes.
Next, RNAi was used to determine whether PI4KII or
PI4KIII was required for translocation of OSBP to the Golgi
apparatus in response to 25-hydroxycholesterol (Figure 9).
In siNT-transfected CHO cells, OSBP was diffusely localized
to the cytoplasm and perinuclear structures but shifted to
the Golgi apparatus after addition of 25-hydroxycholesterol
for 30 min (Figure 9, A and C). Endogenous PI4KII in
siNT-transfected cells was distributed in punctate structures
and in the perinuclear region, a pattern that was not affected
by oxysterol (Figure 9A). OSBP in CHO cells with reduced
PI4KII expression was localized to the perinuclear Golgi
apparatus in the presence of 25-hydroxycholesterol (Figure
9B), indicating that OSBP does not depend on PtdIns(4)P
generated by this PI4K for its translocation.
The localization of OSBP was examined in CHO cells de-
pleted of PI4KIII, which has been implicated in Golgi local-
ization of proteins with PtdIns(4)P-speciﬁc PH domains (Balla
et al., 2005; Toth et al., 2006; Figure 9, C and D). 25-Hydroxy-
cholesterol did not affect the constitutive Golgi localization of
PI4KIII (Figure 9C). OSBP translocated to the Golgi apparatus
in PI4KIII-depleted cells but tended to be more dispersed
than controls, suggesting fragmentation of the Golgi stacks or
partial suppression of OSBP translocation (Figure 9D). Similar
to results with CHO cells, we observed that suppression of
PI4KIIdid not affect the prominent Golgi localization of OSBP
in HeLa cells treated with 25-hydroxycholesterol (Figure 9E).
OSBP also was localized to the Golgi apparatus in HeLa cells
with reduced PI4KIII expression, but again the distribution
was slightly fragmented compared with nontargeting controls
(Figure 9F). Although we cannot discount other sources of
PtdIns(4)P, the lack of involvement of the major Golgi-associ-
ated PI4Ks in OSBP recruitment to the Golgi apparatus con-
ﬁrms it is an upstream regulator of PI4KII activity.
Figure 9. Knockdown of PI4KII or PI4KIII
does not prevent oxysterol-dependent Golgi lo-
calization of OSBP. CHO cells transfected with
siNT (A and C), siPI4KII (B), or siPI4KIII (D)
were treated with ethanol solvent or 25-
hydroxycholesterol (25OH; 2.5 g/ml) for 1 h.
Cells were then ﬁxed and incubated with an
OSBP polyclonal antibody and goat anti-rabbit
Alexa Fluor488 (C and D) or Alexa Fluor594 (A
and B) secondary antibodies, followed by
PI4KII or PI4KIII monoclonal antibodies and
a goat anti-mouse Alexa Fluor594 C and D) or
Alexa Fluor488 (A and B) secondary antibodies.
Images are single confocal sections (0.4–0.2
M) taken on an LSM510/AxioVert 100M in-
verted microscope equipped with a 100 oil
immersion objective (NA 1.4). HeLa cells were
transiently transfected with siPI4KII (E) or
siPI4KIII (F), treated with 25-hydroxycho-
lesterol for 1 h, and immunostained for the
corresponding PI4K and OSBP. Images
were captured on an Axiovert 200M ﬂuores-
cence microscope equipped with a 63 ob-
jective (NA 1.4).
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This study demonstrates that OSBP stimulates a sterol-regu-
lated PI4KII activity in the TGN/endosome compartment
resulting in recruitment of CERT and increased SM synthesis.
Mechanistically, this could involve maintenance or stabiliza-
tion of a cholesterol gradient in the late-Golgi endosomal path-
way that is required for PI4KII activity by the high-afﬁnity
sterol binding and transfer activities of OSBP. By coupling this
function with ceramide transfer through CERT recruitment,
SM and cholesterol content would be maintained within an
optimal range in the early secretory pathway.
The yeast OSBP homologue Osh4p (Prinz, 2007), as well as
OSBP and ORP9L (Ngo and Ridgway, 2009), catalyzed the in
vitro PtdIns(4)P- and PtdIns(4,5)P2-dependent transfer of cho-
lesterol between liposomes. In vivo, this activity could alter
cholesterol or oxysterol distribution in the ER and Golgi mem-
branes with resultant changes in the activity of membrane-
associated proteins such as PI4KII, which associates with
Golgi and endosomal membranes by a cholesterol-dependent
mechanism (Waugh et al., 2006; Minogue et al., 2010). In sup-
port of this model, PI4K activity in Golgi/endosome-enriched
fractions and OG/DOC-resistant membranes from CHO cells
was stimulated by 25-hydroxycholesterol and OSBP, and sen-
sitive to in vitro manipulation of cholesterol using MCD.
PI4KII was required for Golgi recruitment of CERT and in-
creased SM synthesis in 25-hydroxycholesterol–treated CHO
and HeLa cells, activities that are also dependent on OSBP
(Perry and Ridgway, 2006). PI4KII is not associated with lipid
rafts (Waugh et al., 1998; Barylko et al., 2001) but is conﬁned to
a TGN/endosomal environment that is relatively cholesterol
poor but exquisitely sensitive to addition and extraction of
cholesterol (Minogue et al., 2010). Based on density gradient
fractionation, OSBP-depleted of CHO cells caused a signiﬁcant
redistribution of cholesterol from endosome fractions, which
contained the bulk of PI4KII, into lighter fractions enriched in
TGN and caveolin but devoid of PI4KII. These data suggest
that OSBP is required to maintain an membrane cholesterol
environment for PI4PII that is optimal for synthesis of
PtdIns(4)P involved in CERT recruitment and SM synthesis.
This conclusion is slightly at odds with previous work showing
that PtdIns(4)P made by PI4KIII was primarily involved in
constitutive ceramide transport and SM synthesis (Toth et al.,
2006; D’Angelo et al., 2007). However, these studies differed in
the use of a pharmacological inhibitor and [3H]sphingosine as
a biosynthetic precursor, which could be incorporated into
ceramide independently of the de novo biosynthetic pathway
in the ER. Moreover, our experimental design was for mea-
surement of sterol-activated SM synthesis rather then acute
changes in constitutive ceramide transport and SM synthesis.
Although it is established that the PH domain is essential for
Golgi localization of OSBP (Lagace et al., 1997), our study
shows that neither PI4KII nor PI4KIII affected the distribu-
tion of OSBP in the presence or absence of oxysterols. Knock-
down of PI4KIII caused a slight dispersion of OSBP Golgi
staining (Figure 9), but this was due to the requirement of this
PI4K for Golgi integrity rather than inhibition of OSBP trans-
location (Godi et al., 1999). The apparent insensitivity to PI4K
expression was unexpected considering that these kinases
were required for Golgi localization of the OSBP-PH domain
fused to GFP (Wang et al., 2003; Balla et al., 2005) and PI4KIII
colocalized with OSBP in the TGN (Figure 8). There are several
possible explanations for this result: PtdIns(4)P generated by
another PI4K could be substituting for reduced synthesis via
PI4KII or PI4KIII, other lipid or protein ligand(s) for the PH
domain mediate Golgi localization under conditions of limiting
PtdIns(4)P, or other OSBP domains facilitate localization by
PtdIns(4)P-independent mechanisms. The relative lack of sen-
sitivity of OSBP to Golgi PI4Ks is, however, consistent with an
initiating role in recruitment of other PH domain proteins such
as CERT. 25-Hydroxycholesterol also promotes Nir2 recruit-
ment to the Golgi apparatus and increased its interaction with
VAP (Peretti et al., 2008), suggesting that this PtdIns-transfer
protein is required to replenish substrate pools for PtdIns(4)P
synthesis following OSBP activation of PI4KII.
The identiﬁcation of PI4KII as a target for oxysterol and
OSBP regulation provides a plausible mechanism for integra-
tion of cholesterol and SM metabolism at the Golgi apparatus.
In this scenario, cholesterol or oxysterol transfer by OSBP
would provide an optimal membrane environment for PI4KII
in the endosomes or TGN leading to increased PtdIns(4)P
synthesis, recruitment of CERT to the Golgi apparatus and
increased ceramide delivery for SM synthesis, thus counterbal-
ancing increased sterol content of the Golgi, post-Golgi mem-
branes, or both. The equilibrium would reestablish once excess
sterol was adsorbed into SM-enriched membranes. The local-
ization of OSBP, CERT, PI4KII, and PI4KIII at the TGN,
facilitated by VAP and Nir2 (Perry and Ridgway, 2006; Peretti
et al., 2008), in oxysterol-stimulated cells suggests that coregu-
lated lipid transfer by this complex involves targeted short-
range diffusion or contact sites between the ER and TGN
(Olkkonen and Levine, 2004). 25-Hydroxycholesterol or cho-
lesterol could be equally effective in this model because like
cholesterol, 25-hydroxycholesterol forms liquid-ordered raft
domains in vitro (Massey and Pownall, 2006). Also, oxysterols
synthesized as a consequence of increased cellular cholesterol
or taken up by cells could act as surrogate ligands for OSBP,
effectively stimulating SM synthesis more rapidly than choles-
terol due to their increased solubility and afﬁnity for OSBP.
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